Literature DB >> 4571908

The association of urothelial atypism with neoplasia: its importance in treatment and prognosis.

R O Schade, J Swinney.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4571908     DOI: 10.1016/s0022-5347(17)60496-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  9 in total

1.  The effect of calculi on transitional epithelium. A clinical and cytological study.

Authors:  F de Ruiter; M E Beyer-Boon; H J de Voogt
Journal:  Urol Res       Date:  1975-08-08

Review 2.  Tumors of the kidney, ureter, and bladder.

Authors:  W A See; R D Williams
Journal:  West J Med       Date:  1992-05

Review 3.  Carcinoma in situ and treatment options.

Authors:  M Erton; Y Ilker
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

4.  Late recurrence of upper urinary tract urothelial tumours.

Authors:  M G Christensen; P Kirkegaard; F Lund
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

5.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 6.  Superficial bladder carcinoma. Factors affecting the natural history.

Authors:  J M Fitzpatrick
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

7.  Detection of transitional cell carcinoma in bladder by intravesical injection of monoclonal antibodies.

Authors:  D K Chopin; J B deKernion
Journal:  Urol Res       Date:  1986

8.  Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder.

Authors:  G W Chodak; C Haudenschild; R F Gittes; J Folkman
Journal:  Ann Surg       Date:  1980-12       Impact factor: 12.969

9.  Biopsy of apparently normal bladder mucosa in patients with bladder carcinoma and its prognostic importance.

Authors:  H Ozen; D Remzi; A Akdas; S Ruacan
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.